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Isolated abdominal wall actinomycosis in the presence of an intrauterine contraceptive device (IUCD) is extremely rare and
only six such cases have been reported in the literature. We report a case where clinical and radiological examinations
revealed a pseudotumor within the anterior abdominal wall. After being lost to follow-up, the patient presented two years
later with the enlargement of the mass. The mass including the aﬀected anterior abdominal wall was completely excised. The
diagnosis of actinomycosis was established postoperatively by histopathological examination. Further questioning concerning her
gynecologicalhistoryrevealedlong-termuseofthesameIUCD.Surgicalexcisionoftheactinomycoticpseudotumourandremoval
of the IUCD followed by antibiotic therapy resulted in the full recovery of the patient.
1.Introduction
Actinomycosisisararesubacuteorchronicinfectiousdisease
resulting in suppurative and granulomatous inﬂammation.
The disease is caused by anaerobic or facultatively anaerobic,
acid-resistant Gram-positive bacteria of Actinomyces species
[1]. In healthy subjects, Actinomyces is a part of normal
ﬂora of the oral cavity, gastrointestinal tract, and the genital
tract. Healthy mucosa acts as a barrier to the spread of
the organism, but tissues damaged by neoplasm, surgery,
trauma, or foreign body allow multiplication and spread
of actinomycosis [2, 3]. Prolonged use of intrauterine
contraceptive devices (IUCD) in the pelvic region can
account for actinomycotic infections ascending from the
uterus. Actinomycosis of the abdominal wall in the presence
of an IUCD without pelvic or intraperitoneal involvement
is extremely rare [3–8] and poses a diagnostic challenge for
clinicians,asitcanbeconfusedwithmalignancies[9].Inthis
present paper, we report a case of isolated abdominal wall
actinomycosis caused by long-term use of an IUCD. To the
best of our knowledge, only six cases were reported in the
literature regarding primary abdominal wall actinomycosis
in the presence of an IUCD.
2.CaseReport
A 48-year-old Caucasian woman presented with a painful
abdominal wall mass in June, 2003. She did not have any his-
toryoftrauma,surgery,ormalignancy.Physicalexamination
revealed a ﬁxed and ﬁrm mass, about 5cm in size, located
around the umbilicus. The patient was afebrile. Laboratory
parameters including erythrocyte sedimentation rate, com-
plete blood count, C-reactive protein, and tumour markers
wereinnormalvalues.Abdominalmagneticresonanceimag-
ing (MRI) showed an inhomogeneous mass composed of
ﬁbrous bands in the subcutaneous tissue in the periumbilical
region, 6 × 5cm in size, with no visceral involvement.
An incisional biopsy was performed twice within a month2 Case Reports in Medicine
Figure 1: Complete excision of the actinomycotic anterior abdom-
inal wall mass including the aﬀe c t e da b d o m i n a lw a l ls t r u c t u r e s( l e f t
arrow) and the adjacent omentum (right arrow).
under local anesthesia, where diﬀuse ﬁbrosis and exu-
dated suppurations were encountered. The histopathological
examination indicated active chronic inﬂammatory changes,
fat necrosis, and diﬀuse myoﬁbroblastic activity correspond-
ing to the diagnosis of an inﬂammatory pseudotumor.
Microbiological examination and bacterial culture did not
reveal any convincing ﬁndings. After initiating empirical
antibiotic therapy with amoxicillin-clavulanic acid per oral,
the patients was discharged, however, she was lost to
medical follow up. In March 2005, she was readmitted to
our clinic with the deterioration of her symptoms. Repeat
MRI of the abdomen demonstrated the progression of the
pseudotumor which reached a size of approximately 13cm
in diameter within the abdominal wall. Surgical exploration
was decided on the basis of her medical history, previous
histopathological, and the radiological ﬁndings. Following
an abdominal transverse incision, intraoperative ﬁndings
revealed a ﬁbrotic mass of 12 × 13cm within all layers of
the anterior abdominal wall (Figure 1). The omentum was
adherent to the parietal peritoneum underneath the mass.
Thelesionwasexcisedincluding theaﬀectedmusclesandthe
omentum. The resulting abdominal walldefectwasclosed by
implantation of a 20 × 20cm intraperitoneal polypropylene
mesh (Prolene, Ethicon, Johnson & Johnson, Somerville,
NJ, USA). Histopathological examination showed acute and
chronicinﬂammatorychangesduetoactinomycoticcolonies
(Figure 2). Once the diagnosis was conﬁrmed, a further
questioning concerning her gynecological history revealed
that she had been using the same IUCD without change for
eight years. Gynecological examination was unremarkable
except for an IUCD (Multiload Cu-375, Multilan, Organon,
Oss, The Netherlands) which was removed consequently.
Culture results from the IUCD revealed actinomycosis. She
wasprescribedahigh-dose penicillinG(10millionunits/day
for three weeks) therapy and discharged on the seventh
postoperative day without any complication. Oral penicillin
was continued for further eight months. She recovered
uneventfully and has been disease-free for four years.
3. Discussion
Actinomyces bacteria are considered to be saprophytes in
the oral cavity, throughout the gastrointestinal tract and
the female genital tract. Actinomycosis is a chronic abscess-
forming disease predominantly caused by Actinomyces
israelii. Pathologic presentations of actinomycosis include
cervicofacial (50% of cases), abdominal (20%), thoracic
(20%), and pelvic involvement (15%) [10]. The destruction
of mucosal barrier by trauma, operations, immunosuppres-
sion, and chronic inﬂammatory disease is recognized as
predisposing factors for the penetration of the bacteria [9].
There has been a signiﬁcant change in the epidemiology
of the actinomycotic infections over the decades due to
use of IUCDs [11]. Lunca et al. [3] reported that 75% of
actinomycosis cases are seen in women, and 63% of the cases
are associated with IUCD.
IUCDs have a traumatizing eﬀect on endometrium,
causing erosions that, in the presence of preexisting pelvic
inﬂammatory disease or anaerobic infection, create a favor-
able environment for the development of actinomyces [12].
The presence of a long standing IUCD is a well-known
risk factor for actinomycosis. There is a clear relationship
between the risk of colonization and the duration of IUCD
use [3, 5]. A. israelii is present in the reproductive tract
of 1.6–44% of IUCD users and the incidence rises slightly
after two years of IUCD use [13]. There is no doubt that
long-term use of an IUCD represents a risk factor for pelvic
actinomycosis and potentially for secondary dissemination
to a distant site such as in the abdominal wall. The
infection rarely disseminates by either lymphatics or the
hematogenous route [2, 3, 10]. As in the presented case, the
actinomycosis infection was associated with the prolonged
use of IUCD (Multiload Cu-375) which has a normal life-
span of three to ﬁve years.
Histologically, suppurating abscesses with subsequent
necrosis and dense ﬁbrosis are usually seen in actinomycosis.
The abscess cavities grow in size and have avascular thick
walls. It initially creates dense adhesions with contiguous
structures due to extensive ﬁbrosis and in the late stages,
can produce internal or external ﬁstulae [11]. Besides the
anterior abdominal wall, whereon localization is very rare,
actinomycosis can aﬀect the large intestine, liver and biliary
tract, stomach, pancreas, greater omentum, and kidney [9].
Primary actinomycosis of the anterior abdominal wall has
been reported only in 29 cases in the literature by 2010
[2–5, 9, 14–18]. However, the association between the use
of IUCD and the occurrence of isolated abdominal wall
actinomycosis has been sporadically reported. Since the ﬁrst
case described by Adachi et al. [8] in 1985, a Medline search
of the medical literature revealed only six cases in total [3–8].
Actinomycosis has been called “the most misdiagnosed
disease”, and it has been said that “no disease is so often
missedbyexperiencedphysicians”[13].Clinically,thereisno
evidenceofspeciﬁcsymptomsrelatedtoactinomycosisinthe
anteriorabdominalwall.Inlaboratoryanalysis,thedominat-
ingsignsareanemia,leucocytosis,andpositiveinﬂammation
markers. Ultrasonography, computed tomography, or MRI
do not suﬃce to diﬀerentiate between actinomycosis andCase Reports in Medicine 3
(a) (b)
Figure 2: (a) Colonies of actinomyces with surrounding active chronic inﬂammatory cells and diﬀuse ﬁbrosis (hematoxylin and eosin, x40),
and (b) the same focus containing the ﬁlamentous colonies of actinomyces (x400).
other inﬂammatory or neoplastic processes [2, 9]. Pre-
operative diagnosis is rarely established in approximately
only 10% of cases, and the pathology can therefore be
confused with other conditions such as neoplasia or another
inﬂammatory cause [2, 3, 9]. It is also very diﬃcult to isolate
the bacterium from cultures. The culture medium should
be strictly anaerobic and takes between 14 and 21 days to
establish diagnosis. Such a speciﬁc culture request is not
often made if the diagnosis is not suspected. Negative culture
rate was reported to be 76% [3]. This is the reason why a
wide primary resection including the surrounding tissue is
inevitable [2, 9]. In the presented case, the diagnosis could
not be made by the microbiological and histopathological
examinations of the repeated incisional biopsies, which
eventually resulted in the progression of the disease. Thus,
the second operation involved a wide excision of the tumor
with the aﬀected muscles and the abdominal wall defect
was closed by the implantation of an inlay prolene mesh.
Ladurneretal.[2]alsodescribedasimilarsurgicalprocedure
and subsequent implantation of an intraperitoneal mesh in a
case with primary actinomycosis of the anterior abdominal
wall.
It is critical to repair abdominal wall defects with non-
absorbable meshes in the presence of infection. A study by
v a n ’ tR i e te ta l .[ 19] shows that the use of absorbable mesh is
associated with an increased incidence of complications and
mortality when compared to nonabsorbable mesh material.
Polypropylene mesh is the most widely used nonabsorbable
material for abdominal wall replacement and reinforcement
due to its favorable characteristics such as durability, plia-
bility, high-tensile strength, porosity, and good growth of
ﬁbroblasts into the mesh [19, 20]. As in the presented case
with actinomycotic infection, the polypropylene mesh has
not resulted in any complications over a four-year follow-up
period.
Surgical treatment without antibiotic therapy is not
always suﬃcient to achieve a cure of actinomycosis. When
antibiotic therapy is combined with surgery, it is relatively
simpletotreat,andthecurerateismorethan90%[3,10,21].
Penicilin and tetracycline are both eﬀective. Initial treatment
should be parenteral penicillin G in high doses of 10–20
million units per day for two to four weeks and continued
with oral penicilin V at a dose of 2–4g/day. Because of
the extensive necrosis and low vascularity, antimicrobial
therapy should be continued until all signs of inﬂammation
disappear, and this may takefromseveralmonths to a yearor
more [9, 22]. In order to prevent recurrences, users of IUCD
should be suggested to remove the intrauterine device.
In conclusion, isolated actinomycosis of the abdominal
wall in IUCD users is an extremely rare clinical entity.
Preoperative diagnosis is diﬃcult and rarely established.
Long-term use of an IUCD represents a risk factor and
should be removed in such clinical presentations. The
combination of surgery and antibiotic therapy is curative in
most of the cases.
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